Nimbus clinches $125M raise via big donor-backed private financing round following Bristol Myers’ TYK2 approval

The computational chemistry biotech, co-founded in 2009 by VC Bruce Booth, announced its most recent financing round Monday worth $125 million — Nimbus’ fifth big financing in the last seven years. The round includes two new investors: Bain Capital Life Sciences and SV Health Investors. Other previous investors tagged along, including Access Biotechnology, Atlas Venture, BVF Partners L.P., Bill Gates, Lightstone Ventures, Pfizer Ventures, RA Capital Management and SR One.